ACADIA Pharmaceuticals Inc. vs International Business Machines Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.42 (market cap $5.07B), while International Business Machines Corp trades at $237.89 (market cap $224.62B). The key difference: International Business Machines Corp is far larger — about 44.3× ACADIA Pharmaceuticals Inc.'s market cap, and International Business Machines Corp pays a 2.84% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | IBM | |
|---|---|---|
Market Cap | $5.07B | $224.62B |
Sector | Health | Technology |
52-Week High | $29.41 | $329.23 |
52-Week Low | $20.06 | $205.77 |
Enterprise Value | $4.19B | $281.76B |
Volume | — | 4,481,527 |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →